MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Morphine

Morphine 1mg orodispersible tablets sugar free

No stability information

Stability notes for Morphine 1mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Actimorph 1mg orodispersible tablets (Ethypharm UK Ltd)

Morphine 2.5mg orodispersible tablets sugar free

No stability information

Stability notes for Morphine 2.5mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Actimorph 2.5mg orodispersible tablets (Ethypharm UK Ltd)

Morphine 5mg modified-release tablets

Use with caution

Stability notes for Morphine 5mg modified-release tablets

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products MST Continus 5mg prolonged-release tablets (Napp Pharmaceuticals Limited).

Supplier

MST Continus 5mg tablets (Napp Pharmaceuticals Ltd)

Morphine 5mg orodispersible tablets sugar free

No stability information

Stability notes for Morphine 5mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Actimorph 5mg orodispersible tablets (Ethypharm UK Ltd)

Morphine 10mg modified-release capsules

Use with caution

Stability notes for Morphine 10mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the product Zomorph 10mg capsules (Ethypharm UK Ltd).

Supplier

Zomorph 10mg modified-release capsules (Ethypharm UK Ltd)

Morphine 10mg modified-release tablets

Use with caution

Stability notes for Morphine 10mg modified-release tablets

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products MST Continus 10mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Morphgesic SR 10mg tablets (ADVANZ Pharma).

Suppliers

Morphgesic SR 10mg tablets (Advanz Pharma)
MST Continus 10mg tablets (Napp Pharmaceuticals Ltd)

Morphine 10mg orodispersible tablets sugar free

No stability information

Stability notes for Morphine 10mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Actimorph 10mg orodispersible tablets (Ethypharm UK Ltd)

Morphine 10mg tablets

Compatible

Stability notes for Morphine 10mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Sevredol 10mg tablets (Napp Pharmaceuticals Limited).

Supplier

Sevredol 10mg tablets (Napp Pharmaceuticals Ltd)

Morphine 15mg modified-release tablets

Use with caution

Stability notes for Morphine 15mg modified-release tablets

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products MST Continus 15mg prolonged-release tablets (Napp Pharmaceuticals Limited).

Supplier

MST Continus 15mg tablets (Napp Pharmaceuticals Ltd)

Morphine 20mg orodispersible tablets sugar free

No stability information

Stability notes for Morphine 20mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Actimorph 20mg orodispersible tablets (Ethypharm UK Ltd)

Morphine 20mg tablets

Compatible

Stability notes for Morphine 20mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Sevredol 20mg tablets (Napp Pharmaceuticals Limited).

Supplier

Sevredol 20mg tablets (Napp Pharmaceuticals Ltd)

Morphine 30mg capsules

No stability information

Stability notes for Morphine 30mg capsules

There are no stability notes for this medicine.

Supplier

Morphine 30mg capsules (Special Order)

Morphine 30mg modified-release capsules

Use with caution

Stability notes for Morphine 30mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the products MXL 30mg prolonged release capsules (Napp Pharmaceuticals Limited) and Zomorph 30mg capsules (Ethypharm UK Ltd).

Suppliers

MXL 30mg capsules (Napp Pharmaceuticals Ltd)
Zomorph 30mg modified-release capsules (Ethypharm UK Ltd)

Morphine 30mg modified-release tablets

Use with caution

Stability notes for Morphine 30mg modified-release tablets

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products MST Continus 30mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Morphgesic SR 30mg tablets (ADVANZ Pharma).

Suppliers

Morphgesic SR 30mg tablets (Advanz Pharma)
MST Continus 30mg tablets (Napp Pharmaceuticals Ltd)

Morphine 30mg orodispersible tablets sugar free

No stability information

Stability notes for Morphine 30mg orodispersible tablets sugar free

There are no stability notes for this medicine.

Supplier

Actimorph 30mg orodispersible tablets (Ethypharm UK Ltd)

Morphine 50mg tablets

Compatible

Stability notes for Morphine 50mg tablets

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Sevredol 50mg tablets (Napp Pharmaceuticals Limited).

Supplier

Sevredol 50mg tablets (Napp Pharmaceuticals Ltd)

Morphine 60mg capsules

No stability information

Stability notes for Morphine 60mg capsules

There are no stability notes for this medicine.

Supplier

Morphine 60mg capsules (Special Order)

Morphine 60mg modified-release capsules

Use with caution

Stability notes for Morphine 60mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the products MXL 60mg prolonged release capsules (Napp Pharmaceuticals Limited) and Zomorph 60mg capsules (Ethypharm UK Ltd).

Suppliers

MXL 60mg capsules (Napp Pharmaceuticals Ltd)
Zomorph 60mg modified-release capsules (Ethypharm UK Ltd)

Morphine 60mg modified-release tablets

Use with caution

Stability notes for Morphine 60mg modified-release tablets

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products MST Continus 60mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Morphgesic SR 60mg tablets (ADVANZ Pharma).

Suppliers

Morphgesic SR 60mg tablets (Advanz Pharma)
MST Continus 60mg tablets (CST Pharma Ltd)
MST Continus 60mg tablets (Napp Pharmaceuticals Ltd)

Morphine 90mg modified-release capsules

Use with caution

Stability notes for Morphine 90mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the product MXL 90mg prolonged release capsules (Napp Pharmaceuticals Limited)

Supplier

MXL 90mg capsules (Napp Pharmaceuticals Ltd)

Morphine 100mg modified-release capsules

Use with caution

Stability notes for Morphine 100mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the product Zomorph 100mg capsules (Ethypharm UK Ltd).

Supplier

Zomorph 100mg modified-release capsules (Ethypharm UK Ltd)

Morphine 100mg modified-release tablets

Use with caution

Stability notes for Morphine 100mg modified-release tablets

Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products MST Continus 100mg prolonged-release tablets (Napp Pharmaceuticals Limited) and Morphgesic SR 100mg tablets (ADVANZ Pharma).

Suppliers

Morphgesic SR 100mg tablets (Advanz Pharma)
MST Continus 100mg tablets (CST Pharma Ltd)
MST Continus 100mg tablets (Napp Pharmaceuticals Ltd)

Morphine 120mg modified-release capsules

Use with caution

Stability notes for Morphine 120mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the product MXL 120mg prolonged release capsules (Napp Pharmaceuticals Limited).

Supplier

MXL 120mg capsules (Napp Pharmaceuticals Ltd)

Morphine 150mg modified-release capsules

Use with caution

Stability notes for Morphine 150mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the product MXL 150mg prolonged release capsules (Napp Pharmaceuticals Limited)

Supplier

MXL 150mg capsules (Napp Pharmaceuticals Ltd)

Morphine 200mg capsules

No stability information

Stability notes for Morphine 200mg capsules

There are no stability notes for this medicine.

Supplier

Morphine 200mg capsules (Special Order)

Morphine 200mg modified-release capsules

Use with caution

Stability notes for Morphine 200mg modified-release capsules

Protect from light. Moisture sensitive medicine. Store in airtight (sealed) MCA. No stability data in MCAs available.

Provenance

This recommendation is based on the products MXL 200mg prolonged release capsules (Napp Pharmaceuticals Limited) and Zomorph 200mg capsules (Ethypharm UK Ltd).

Suppliers

MXL 200mg capsules (Napp Pharmaceuticals Ltd)
Zomorph 200mg modified-release capsules (Ethypharm UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.